After losing 17% in the past year, Century Therapeutics, Inc. (NASDAQ:IPSC) institutional owners must be relieved by the recent gain [Yahoo! Finance]
Century Therapeutics, Inc. (IPSC)
Company Research
Source: Yahoo! Finance
50% of the business is held by the top 5 shareholders Recent sales by insiders To get a sense of who is truly in control of Century Therapeutics, Inc. ( NASDAQ:IPSC ), it is important to understand the ownership structure of the business. With 29% stake, institutions possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company. After a year of 17% losses, last week's 14% gain would be welcomed by institutional investors as a possible sign that returns might start trending higher. Let's delve deeper into each type of owner of Century Therapeutics, beginning with the chart below. View our latest analysis for Century Therapeutics What Does The Institutional Ownership Tell Us About Century Therapeutics? Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the re
Show less
Read more
Impact Snapshot
Event Time:
IPSC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPSC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPSC alerts
High impacting Century Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
IPSC
News
- Century Therapeutics, Inc. (NASDAQ: IPSC) had its price target lowered by analysts at HC Wainwright from $11.00 to $9.00. They now have a "buy" rating on the stock.MarketBeat
- Century Therapeutics, Inc. (IPSC) Reports Q2 Loss, Tops Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Century Therapeutics, Inc. (NASDAQ: IPSC) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $6.00 price target on the stock.MarketBeat
- Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates [Yahoo! Finance]Yahoo! Finance
- Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdatesGlobeNewswire
IPSC
Earnings
- 5/9/24 - Beat
IPSC
Sec Filings
- 9/16/24 - Form 4
- 8/8/24 - Form 8-K
- 8/8/24 - Form 10-Q
- IPSC's page on the SEC website